Anti-VEGF dugs may slow age-related macular degeneration, study shows

Anti-VEGF dugs may slow age-related macular degeneration, study shows

(Bethesda, MD – Insurance News and Markets) – The National Institutes of Health recently announced the publication of a study looking at treatment with anti-VEGF drugs for more than 600individuals who had age-related macular degeneration, or AMD.  With five years of treatment with anti-VEGF drugs, half of those in the study still had20/40 vision, or better. […]

Special cells prepare for rapid response to infection, NIH reports

Special cells prepare for rapid response to infection, NIH reports

(Bethesda, MD – Insurance News and Markets) – The National Institutes of Health (NIH) recently announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS) have learned about immune cells, called innate lymphoid cells (ILCS) that are prepared for rapid response to infection. The information, published online in “Cell” on May 5, […]

Three genes related to glaucoma are found

Three genes related to glaucoma are found

(Bethesda, MD – Insurance News and Markets) – The National Eye Institutes (an area of the National Instititues of Health) has discovered three more genes that are involved in the most common type of glaucoma. This brings the total of such genes to 15. “Just in time for Glaucoma Awareness Month, this unprecedented analysis provides […]

Opioid induced deaths hit record level in 2014

Opioid induced deaths hit record level in 2014

(Atlanta, GA – Insurance News and Markets) – In 2014, deaths from pain relievers, heroin and other opioid drogs reached a record level, increasing 14 percent over the 2013 levels, according to the Center for Disease Control’s Morbidity and Mortality Weekly Report. Natural or semi-synthetic opioids, like as oxycodone and hydrocodone are the most commonly-prescribed […]

New Ebola treatment in development

New Ebola treatment in development

(Washington, D.C. – Insurance News and Markets) – The U.S. Department of Health and Human Services (HHS) announced in September that a new treatment for the Ebola virus will proceed in development, thanks to an agreement between several agencies, including the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron Pharmaceuticals, […]

1 2 3